Fibrosis Lessens After Metabolic Surgery

Clinical trial NCT06374875 · RECRUITING

Trial details

NCT number: NCT06374875
Sponsor: The Cleveland Clinic
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Non-Alcoholic Fatty Liver Disease Metabolic Dysfunction-Associated Steatohepatitis (MASH)Liver Fibrosis Obesity

Start date: 2024-07-11
Primary completion: 2029-05-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.